Dean Petkanas, Chief Executive Officer, 10% Owner at NEUROPATHIX, INC. (NPTX), sold 500,000 shares at $0.05 ($13K) on 2022-01-05, disclosed to the SEC on 2022-01-07.
Scheduled sale ($12k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.05 | 89,000 | $4K | 35.6% |
| 2 | $0.05 | 120,000 | $6K | 48.0% |
| 3 | $0.00 | 250,000 | $0 | 0.0% |
| 4 | $0.05 | 41,000 | $2K | 16.4% |
| Total | $0.03 avg | 500,000 | $13K | 100% |
| Filing → |
| KLFE | SELL | 2019-12-03 | $100K | — | Filing → |